Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation

Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutationPreferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation, Published online: 09 May 2019; doi:10.1038/s41417-019-0099-5Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation

Source: Cancer Gene Therapy - May 8, 2019 Category: Cancer & Oncology Authors: Malte Hellwig Daniel J. Merk Beat Lutz Ulrich Sch üller Source Type: research